IBEX TECHNOLOGIES INC. — Investor Relations & Filings
Filings indexed
122
across all filing types
Latest filing
2024-05-24
Regulatory Filings
Country
CA
Canada
Listing
TSXV
IBT
IBEX Technologies Inc. develops, manufactures, and markets high-purity enzymes and specialized reagents for biomedical use. The company's product portfolio includes a family of proprietary enzymes utilized in pharmaceutical research, notably for applications in arthritis and oncology, and diagnostic products. IBEX serves the In Vitro Diagnostics (IVD) sector and general research markets by supplying essential raw materials.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Decision Document / Order for Application - French.pdf | 2024-05-24 | English | |
| Material change report - English.pdf | 2024-04-08 | English | |
| News release - English.pdf | 2024-04-08 | English | |
| News release - English.pdf | 2024-04-08 | English | |
| Material change report - English.pdf | 2024-04-03 | English | |
| News release - English.pdf | 2024-04-03 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 30148826 | Decision Document / Order for Application - French.pdf | 2024-05-24 | English | ||
| 29760856 | Material change report - English.pdf | 2024-04-08 | English | ||
| 29760993 | News release - English.pdf | 2024-04-08 | English | ||
| 29760953 | News release - English.pdf | 2024-04-08 | English | ||
| 13730488 | Material change report - English.pdf | 2024-04-03 | English | ||
| 13730501 | News release - English.pdf | 2024-04-03 | English | ||
| 13727927 | Material document(s).pdf | 2024-03-14 | English | ||
| 13727926 | Material document(s).pdf | 2024-03-14 | English | ||
| 13727924 | Material document(s).pdf | 2024-03-14 | English | ||
| 13728244 | News release - English.pdf | 2024-03-14 | English | ||
| 13726819 | Management information circular (amended) - English.pdf | 2024-03-13 | English | ||
| 13721729 | News release - English.pdf | 2024-02-23 | English | ||
| 13721825 | Form of proxy - English.pdf | 2024-02-23 | English | ||
| 13721823 | Other.pdf | 2024-02-23 | English | ||
| 13721822 | Other.pdf | 2024-02-23 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apellis Pharmaceuticals, Inc.
Biopharmaceutical company developing therapies by targeting…
|
APLS | US | Manufacturing |
|
Apeloa Pharmaceutical Co.,Ltd.
Integrated provider of APIs, CDMO services, and finished dr…
|
000739 | CN | Manufacturing |
|
ApicHope Pharmaceutical Group Co.,Ltd
Pharmaceutical firm focused on pediatric, chronic, and card…
|
300723 | CN | Manufacturing |
|
Apimeds Pharmaceuticals US, Inc.
Clinical-stage biopharma developing a bee venom drug and AI…
|
APUS | US | Manufacturing |
|
Apogee Therapeutics, Inc.
Clinical-stage biotech developing biologics for immunologic…
|
APGE | US | Manufacturing |
|
Apollomics Inc.
Clinical-stage biotech developing innovative oncology and c…
|
APLM | US | Manufacturing |
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode Corporation
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
IBEX TECHNOLOGIES INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/42661/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=42661 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=42661 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=42661 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 42661}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IBEX TECHNOLOGIES INC. (id: 42661)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.